Newsletter
ReActiv8 Restorative Neurostimulation: A Novel, Long-term Treatment Option for Mechanical Chronic Low Back Pain with Jason Hannon, CEO and Executive Director at Mainstay Medical International

Outcomes Rocket

ReActiv8 Restorative Neurostimulation: A Novel, Long-term Treatment Option for Mechanical Chronic Low Back Pain with Jason Hannon, CEO and Executive Director at Mainstay Medical International

September 12, 2022

ReActiv8 Restorative Neurostimulation: A Novel, Long-term Treatment Option for Mechanical Chronic Low Back Pain with Jason Hannon, CEO and Executive Director at Mainstay Medical International

Creating a different approach to helping patients with back pain is a daunting task, but ReActiv8 is doing it with flying colors.

In this episode, we hear from Jason Hannon, executive director, and CEO at Mainstay Medical, about ReActiv8, a new groundbreaking therapy approach to help patients with back pain; This is the first back pain therapy focused on the cause and not just on its symptoms. Jason explains how ReActiv8 works through neural stimulation with the patient’s participation to activate the muscle-generating stability in the spine. He discusses the results of a three-year study that show significant improvement for the patients who participated, an exciting outcome for back pain treatment. He also speaks of the challenges that come with entering the market after being so research-driven while being excited about what this type of therapy could represent for chronic pain management.

Tune in to this episode to learn how ReActiv8 could be a paradigm shift for back pain treatment!

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Treatment for Alzheimer’s Disease: Diet, Exercise and Lifestyle Changes Hear from people living with Alzheimer's about lifestyle changes they’ve adopted to continue leading active, social lives.